probenecid has been researched along with Leukemia, Myeloid in 1 studies
Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.
Leukemia, Myeloid: Form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (MYELOID PROGENITOR CELLS) in the bone marrow and other sites.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsimberidou, AM | 1 |
| Paterakis, G | 1 |
| Androutsos, G | 1 |
| Anagnostopoulos, N | 1 |
| Galanopoulos, A | 1 |
| Kalmantis, T | 1 |
| Meletis, J | 1 |
| Rombos, Y | 1 |
| Sagriotis, A | 1 |
| Symeonidis, A | 1 |
| Tiniakou, M | 1 |
| Zoumbos, N | 1 |
| Yataganas, X | 1 |
1 other study available for probenecid and Leukemia, Myeloid
| Article | Year |
|---|---|
Evaluation of the clinical relevance of the expression and function of P-glycoprotein, multidrug resistance protein and lung resistance protein in patients with primary acute myelogenous leukemia.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; | 2002 |